IMV Announces Phase 2 Basket Trial in Collaboration with Merck to Evaluate DPX-Survivac in Combination with KEYTRUDA Across Five Solid Tumor Indications
SAGA Metals Announces Expiry of Warrant Acceleration Program and Receipt of C$3,422,888 in Warrant Proceeds since January 1, 2026
